A monovalent attenuated serotype 2 bluetongue virus vaccine confers homologous protection in sheep
| dc.contributor.author | Hunter, P. | |
| dc.contributor.author | Modumo, J. | |
| dc.contributor.editor | Boomker, Jacob Diederik Frederik | |
| dc.date.accessioned | 2012-12-12T06:36:50Z | |
| dc.date.available | 2012-12-12T06:36:50Z | |
| dc.date.created | 2012 | |
| dc.date.issued | 2001 | |
| dc.description | The articles have been scanned in colour with a HP Scanjet 5590; 600dpi. Adobe Acrobat v.9 was used to OCR the text and also for the merging and conversion to the final presentation PDF-format. | en_US |
| dc.description.abstract | An outbreak of bluetongue caused by bluetongue virus serotype 2 virus in certain Mediterranean countries during 1999/2000, presented an opportunity to produce a monovalent type 2 vaccine. Since no data have been published previously on the protection conferred by the current live attenuated bluetongue vaccine strains used in the polyvalent vaccine, a challenge experiment was performed to determine the degree of homologous protection induced by the type 2 vaccine strain. The standard vaccine dose of 5X10⁴ pfu of vaccine conferred 99.7% protection against clinical disease and no viraemia was detected in the vaccinates. | en_US |
| dc.identifier.citation | Hunter, P & Modumo, J 2001, 'A monovalent attenuated serotype 2 bluetongue virus vaccine confers homologous protection in sheep’. Onderstepoort Journal of Veterinary Research, vol. 68, no. 4, pp. 331-333. | en_US |
| dc.identifier.issn | 0030-2465 | |
| dc.identifier.uri | http://hdl.handle.net/2263/20687 | |
| dc.language | en | |
| dc.publisher | Published jointly by the Agricultural Research Council, ARC-Onderstepoort Veterinary Institute and the Faculty of Veterinary Science, University of Pretoria. | en_US |
| dc.rights | © ARC-Onderstepoort and Faculty of Veterinary Science, University of Pretoria (original). © University of Pretoria. Dept of Library Services (digital). | en_US |
| dc.subject | Veterinary medicine | en_US |
| dc.subject | Attenuated | en_US |
| dc.subject | Bluetongue vaccine | en_US |
| dc.subject | Mediterranean countries | en_US |
| dc.subject | Monovalent | en_US |
| dc.subject | Serotype 2 | en_US |
| dc.subject.lcsh | Veterinary medicine -- South Africa | |
| dc.title | A monovalent attenuated serotype 2 bluetongue virus vaccine confers homologous protection in sheep | en_US |
| dc.type | Article | en_US |